Mechanisms of cisplatin- and m-chlorophenylbiguinide-induced emesis in ferrets
- 20 July 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 238 (2-3) , 369-376
- https://doi.org/10.1016/0014-2999(93)90868-i
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cisplatin induced emesis: preliminary results indicative of changes in plasma levels of 5-hydroxytryptamineBritish Journal of Cancer, 1990
- Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stemNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticityCanadian Journal of Physiology and Pharmacology, 1990
- Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonistBritish Journal of Cancer, 1988
- The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694British Journal of Cancer, 1988
- Neuropharmacology of emesis induced by anti-cancer therapyTrends in Pharmacological Sciences, 1988
- Reserpine, para-chlorophenylalanine and fenfluramine antagonise cisplatin-induced emesis in the ferretNeuropharmacology, 1988
- The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.BMJ, 1988
- 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesisNeuropharmacology, 1986